|
|
|
|
A Shape-Shifting Tail Decay is the Pharmacokinetic ;
Profile of an Ultra-Long Acting Bictegravir Prodrug
|
|
|
CROI 2024 March 3-6 Denver
Mohammad Ullah Nayan1, Ivana Massud3, Brady Sillman1, Srijanee Das2, Brandon Hanson1, Arpan Acharya1, Tiancheng Edwards3, Richard Haaland3, Siddappa N. Byrareddy1,
J. Gerardo Garcίa-Lerma3, Walid Heneine3, Charles W. Dobard3, Howard E. Gendelman1, and Benson Edagwa1
1Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA
2Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, 68198, USA
3Laboratory Branch, Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
|
|
|
|
|
|
|